Showing results (291-300 of 435) with videos related to
Sort By:
Pageof 44
BMC Cancer|July 22, 2025
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approachAndrew J Pellatt, Reagan M Barnett, Sante Gnerre, et al.JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistanceScott Kopetz, Paulo M Hoff, Jeffrey S Morris, et al.Journal of Experimental & Clinical Cancer Research : CR|March 29, 2023
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumorsChristopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.Clinical Colorectal Cancer|February 4, 2020
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal CancerShailesh M Advani, Quilling Shi, Michael J Overman, et al.Hepatology (Baltimore, Md.)|December 23, 2018
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract CancerChangqing Xie, Austin G Duffy, Donna Mabry-Hrones, et al.The Journal of Molecular Diagnostics : JMD|May 17, 2017
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic AcidMeenakshi Mehrotra, Rajesh R Singh, Wei Chen, et al.Oncotarget|August 20, 2016
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentinMichael J Overman, Van Morris, Helen Moinova, et al.Plos One|October 17, 2015
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNARichard B Lanman, Stefanie A Mortimer, Oliver A Zill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2022
Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of TherapyChristine M Parseghian, Ryan Sun, Melanie Woods, et al.Pageof 44